Aspire Biopharma Holdings (ASBP) Treasury Shares (2022 - 2024)

Aspire Biopharma Holdings (ASBP) has 3 years of Treasury Shares data on file, last reported at $577644.0 in Q4 2024.

• On a quarterly basis, Treasury Shares fell 67.98% year-over-year to $577644.0 in Q4 2024; TTM through Dec 2024 was $577644.0, a 67.98% decrease from a year earlier, with the FY2024 full-year figure at $577644.0, down 67.98% from the prior year.
• Treasury Shares for Q4 2024 stood at $577644.0, roughly flat from $577644.0 in the prior quarter.
• Over the last five years, Treasury Shares for ASBP reached as high as $28.8 million in Q4 2022 and fell as low as $577644.0 in Q2 2024.
• Historically, Treasury Shares has averaged $7.4 million across 3 years, with a median of $1.8 million in 2023.
• Across the five-year window, Treasury Shares sank 93.73% in 2023 and tumbled 67.98% in 2024, its largest moves.
• Year by year, Treasury Shares stood at $28.8 million in 2022, then sank by 93.73% to $1.8 million in 2023, then tumbled by 67.98% to $577644.0 in 2024.
• Per Business Quant data, the three most recent Treasury Shares figures were $577644.0 in Q4 2024, $577644.0 in Q3 2024, and $577644.0 in Q2 2024.